Riskpilot← Back to searchSign inGet full accessZenzeTech ApS
APSBankruptCVR 41657219Diplomvej 381Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20206 employees
Revenue 2023
DKK 148K
-111% vs 2022
EBITDA margin
-739.8%
+37% vs 2022
Equity ratio
85.8%
Financial strength
Net profit 2023
DKK -979K
+34% vs 2022
| Revenue | DKK 148K | -111% |
| EBITDA | DKK -1,1M | +37% |
| Net profit | DKK -979K | +34% |
| Total assets | DKK 1,6M | +165% |
| Equity | DKK 1,3M | +296% |
| Employees | 6 | — |
Legal name
ZenzeTech ApS
CVR number
41657219
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1. september 2020
Share capital
DKK 63.183
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør og bestyrelsesformanden i forening, to bestyrelsesmedlemmer i forening, eller af den samlede bestyrelse
Address
Diplomvej 381
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | -142 | -1.324 | 148 |
| Staff expenses | -123 | -418 | -1.243 |
| EBITDA | -265 | -1.742 | -1.095 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -265 | -1.742 | -1.095 |
| Net financials | -5 | -5 | -8 |
| Profit before tax | -269 | -1.747 | -1.103 |
| Tax | -25 | -270 | -124 |
| Net profit | -245 | -1.478 | -979 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 814 | 589 | 1.560 |
| Equity | 795 | -682 | 1.338 |
| Long-term debt | 0 | 1.000 | 0 |
| Short-term debt | 19 | 272 | 221 |
| Total debt | 19 | 1.272 | 221 |
EBITDA margin
-739.8%
This company
15.8%
Market median
-4782% vs market
20212023
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
20212023
Return on equity
-73.2%
This company
18.4%
Market median
-498% vs market
20212023
Net profit margin
-661.6%
This company
8.1%
Market median
-8268% vs market
20212023
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20212023
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212023
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-09-01 – 2021-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CB Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
PR Management | Management | 2020 | — | — |
MP Management | Management | 2020 | — | — |
JH Management | Management | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JHallengreen Holding ApS | Company | 20.0% | 20.0% | 2020 |
RESEN HOLDING ApS | Company | 15.0% | 15.0% | 2022 |
ZenzeTech ApS | Company | 15.0% | 15.0% | 2023 |
Paul Holding ApS | Company | 15.0% | 15.0% | 2022 |
| Individual | 25.0% | 25.0% | 2022 | |
CB.Haahr Holding ApS | Company | 15.0% | 15.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ZenzeTech ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Bygballe Haahr | Chief Executive Officer | 0 companies |
| Per Resen Steenstrup | Management | 0 companies |
| Magdalena Paul | Management | 0 companies |
| Jesper Hallengreen | Management | 0 companies |
| Martin Rask Bonnen | Chairman | 0 companies |
| Erik Gormsen | Board of Directors | 0 companies |